IN2014KN01208A - - Google Patents

Info

Publication number
IN2014KN01208A
IN2014KN01208A IN1208KON2014A IN2014KN01208A IN 2014KN01208 A IN2014KN01208 A IN 2014KN01208A IN 1208KON2014 A IN1208KON2014 A IN 1208KON2014A IN 2014KN01208 A IN2014KN01208 A IN 2014KN01208A
Authority
IN
India
Prior art keywords
teicoplanin
decoloured
colours
eluted
cation
Prior art date
Application number
Other languages
English (en)
Inventor
Samo Andrensek
Rok Grahek
Tomaz Marko
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Publication of IN2014KN01208A publication Critical patent/IN2014KN01208A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN1208KON2014 2011-11-11 2012-11-09 IN2014KN01208A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11188776.6A EP2592090A1 (en) 2011-11-11 2011-11-11 Process of purification of teicoplanin
PCT/EP2012/072226 WO2013068517A1 (en) 2011-11-11 2012-11-09 Process of purification of teicoplanin

Publications (1)

Publication Number Publication Date
IN2014KN01208A true IN2014KN01208A (sl) 2015-10-16

Family

ID=47172623

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1208KON2014 IN2014KN01208A (sl) 2011-11-11 2012-11-09

Country Status (10)

Country Link
EP (2) EP2592090A1 (sl)
KR (1) KR102040344B1 (sl)
CN (1) CN104080798A (sl)
DK (1) DK2776453T3 (sl)
ES (1) ES2558603T3 (sl)
HU (1) HUE026336T2 (sl)
IN (1) IN2014KN01208A (sl)
PL (1) PL2776453T3 (sl)
SI (1) SI2776453T1 (sl)
WO (1) WO2013068517A1 (sl)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) 1975-03-05 1977-12-30 Lepetit Spa Antibiotics
GB8608798D0 (en) 1986-04-11 1986-05-14 Lepetit Spa Recovery of glycopeptide antibiotics from aqueous solutions
US4845194A (en) 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
ES2076436T3 (es) 1990-10-01 1995-11-01 Lepetit Spa Procedimiento de recuperacion de teicoplanina.
KR100321304B1 (ko) 1999-04-16 2002-03-18 박호군 테이코플라닌의 정제방법
KR100367890B1 (ko) 2000-03-02 2003-01-14 은언기 랩핑/폴리싱 휠 및 그 제조방법
KR20030017067A (ko) 2001-08-23 2003-03-03 정용진 변이주 액티노플라네스 테이코마이세티커스 지안네시스 및이로부터 테이코플라닌을 생산하는 방법
KR100459289B1 (ko) 2002-05-30 2004-12-03 이연제약주식회사 발효액으로부터 테이코플라닌a₂의 회수방법
KR100476818B1 (ko) * 2002-07-19 2005-03-17 종근당바이오 주식회사 테이코플라닌 에이 투 정제 방법
KR100652320B1 (ko) * 2004-02-16 2006-11-29 근화제약주식회사 테이코플라닌의 분리 및 정제 방법
KR100474653B1 (ko) * 2004-04-16 2005-03-14 동국제약 주식회사 타이코플라닌의 고순도 생산방법
KR100554481B1 (ko) * 2004-06-30 2006-03-03 씨제이 주식회사 반코마이신 염산염의 정제방법
SI1805211T1 (sl) * 2004-10-27 2009-08-31 Axellia Pharmaceuticals Aps Äśiĺ äśenje glikopeptidov
EP1798237A1 (en) * 2005-12-16 2007-06-20 Pharmatex Italia Srl Process for the purification of macrolide antibiotics

Also Published As

Publication number Publication date
EP2592090A1 (en) 2013-05-15
EP2776453A1 (en) 2014-09-17
KR20140091738A (ko) 2014-07-22
SI2776453T1 (sl) 2016-04-29
EP2776453B1 (en) 2015-10-07
HUE026336T2 (en) 2016-05-30
CN104080798A (zh) 2014-10-01
KR102040344B1 (ko) 2019-11-04
DK2776453T3 (en) 2016-01-18
WO2013068517A1 (en) 2013-05-16
ES2558603T3 (es) 2016-02-05
PL2776453T3 (pl) 2016-03-31

Similar Documents

Publication Publication Date Title
EP3740566A4 (en) METHOD OF DIFFERENTIATING HUMAN PLURIPOTENT STEM CELL LINES IN A SUSPENSION CULTURE
MX2015006681A (es) Formulaciones de vancomicina estabilizadas.
MX2019008914A (es) Purificacion de iduronato-2-sulfatasa.
GB201016733D0 (en) Compounds and their use
IL197003A0 (en) Purification process of echinocandin-type compounds
MY179664A (en) Microorganisms and methods for the biosynthesis of butadiene
BR112012029389A2 (pt) injeção bacteriana na cana de açúcar
MX2020003798A (es) Metodos para la purificacion de arilsulfatasa a.
WO2011008516A3 (en) Methods and compositions for affecting the differentiation of clostridia in culture
MY171760A (en) Microorganisms and methods for the production of caprolactone
WO2011090720A3 (en) Purification of proteins
IN2014KN01208A (sl)
MX2016000413A (es) Metodos de adsorcion de lecho expandido para aislamiento de proteinas basicas de la leche incluyendo la lactoferrina.
EP2740479A4 (en) COMPOSITION WITH ANTIBIOTICS AND LYSOPHOSPHATIDYLCHOLIN TO INCREASE IMMUNITY AGAINST TREATMENT OF BACTERIAL INFECTIONS
MX2019007072A (es) Procedimiento para la purificacion de antibioticos lipopolipeptidicos.
EP2615157A3 (en) Enzyme cleaning composition and method of use
GB202113077D0 (en) Composition for 3D tissue culture
EP2217700A4 (en) SYSTEM AND METHOD FOR PRODUCING SYNTHETIC MICROORGANISMS CAPABLE OF TRANSLATING PROTEINS CONTAINING NON-STANDARD AMINO ACIDS
EP3921856A4 (en) SYSTEM AND METHOD FOR DISTURBING AN ASYMMETRIC PERMANENT MAGNETIC FIELD FOR MOTION OF A BODY
EP4031652A4 (en) LOW-COST CULTURE MEDIA AND PROTOCOL FOR HUMAN INDUCED PLURIPOTENT STEM CELLS
IL272502A (en) A device for improving the growth of microorganisms in liquid culture
GB201908317D0 (en) Carbon compound production in photosynthetic microorganisms
MX2012001875A (es) Proceso para la preparación de inhibidores de la catepsina s.
EP3911728A4 (en) SCALABLE MANUFACTURING AND CULTIVATION SYSTEMS FOR PHOTOSYNTHETIC MICROORGANISMS
IL307362A (en) Variants of bacterial strains and processes for protein or biomass production